Cargando…

HOXD‐AS2‐STAT3 feedback loop attenuates sensitivity to temozolomide in glioblastoma

AIMS: Glioblastoma multiforme (GBM) is the deadliest glioma and its resistance to temozolomide (TMZ) remains intractable. Long non‐coding RNAs (lncRNAs) play crucial roles in that and this study aimed to investigate underlying mechanism of HOXD‐AS2‐affected temozolomide sensitivity in glioblastoma....

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Zuo‐Xin, Ren, Peng, Cao, Yong‐Yong, Wang, Ting‐Ting, Huang, Guo‐Hao, Li, Yao, Zhou, Shuo, Yang, Wei, Yang, Lin, Liu, Guo‐Long, Xiang, Yan, Pei, Yu‐Chun, Chen, Qiu‐Zi, Chen, Ju‐Xiang, Lv, Sheng‐Qing
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2023
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10580348/ https://www.ncbi.nlm.nih.gov/pubmed/37308741 http://dx.doi.org/10.1111/cns.14277

Ejemplares similares

A Positive Feedback Loop of lncRNA HOXD-AS2 and SMYD3 Facilitates Hepatocellular Carcinoma Progression via the MEK/ERK Pathway
por: Sun, Jin, et al.
Publicado: (2023)

AKT2-knockdown suppressed viability with enhanced apoptosis, and attenuated chemoresistance to temozolomide of human glioblastoma cells in vitro and in vivo
por: Cui, Yong, et al.
Publicado: (2015)

Identification of HOXD10 as a Marker of Poor Prognosis in Glioblastoma Multiforme
por: Li, Yanxin, et al.
Publicado: (2021)

miR-29a sensitizes the response of glioma cells to temozolomide by modulating the P53/MDM2 feedback loop
por: Chen, Qiudan, et al.
Publicado: (2021)

Coixendide efficacy in combination with temozolomide in glioblastoma and transcriptome analysis of the mechanism
por: Zhao, Zhenran, et al.
Publicado: (2023)

Ovarian cancer variant rs2072590 is associated with HOXD1 and HOXD3 gene expression
por: Guo, Liyuan, et al.
Publicado: (2017)

Identification of Key Candidate Proteins and Pathways Associated with Temozolomide Resistance in Glioblastoma Based on Subcellular Proteomics and Bioinformatical Analysis
por: Yi, Guo-zhong, et al.
Publicado: (2018)

A pan-cancer analysis of the role of HOXD1, HOXD3, and HOXD4 and validation in renal cell carcinoma
por: Wang, Lumin, et al.
Publicado: (2023)

Temozolomide-Induced RNA Interactome Uncovers Novel LncRNA Regulatory Loops in Glioblastoma
por: Fritah, Sabrina, et al.
Publicado: (2020)

Cost-effectiveness analysis of the addition of bevacizumab to temozolomide therapy for the treatment of unresected glioblastoma
por: Chen, Zhaoyan, et al.
Publicado: (2020)

Novel predictive epigenetic signature for temozolomide in non-G-CIMP glioblastomas
por: Yin, An-An, et al.
Publicado: (2019)

RPL22L1, a novel candidate oncogene promotes temozolomide resistance by activating STAT3 in glioblastoma
por: Chen, Yunping, et al.
Publicado: (2023)

Anlotinib combined with temozolomide suppresses glioblastoma growth via mediation of JAK2/STAT3 signaling pathway
por: Xu, Peng, et al.
Publicado: (2022)

Repurposing Penfluridol in Combination with Temozolomide for the Treatment of Glioblastoma
por: Kim, Hyungsin, et al.
Publicado: (2019)

Temozolomide resistance in glioblastoma multiforme
por: Lee, Sang Y.
Publicado: (2016)

Nuclear lncRNA HOXD-AS1 suppresses colorectal carcinoma growth and metastasis via inhibiting HOXD3-induced integrin β3 transcriptional activating and MAPK/AKT signalling
por: Yang, Min-Hui, et al.
Publicado: (2019)

Continuous Low-Dose Temozolomide Chemotherapy and Microvessel Density in Recurrent Glioblastoma
por: Woo, Jong-Yun, et al.
Publicado: (2015)

Decreased expression of the long non-coding RNA HOXD-AS2 promotes gastric cancer progression by targeting HOXD8 and activating PI3K/Akt signaling pathway
por: Yao, Lin, et al.
Publicado: (2020)

Anti-PD-1, anti-VEGF, and temozolomide therapy in a patient with recurrent glioblastoma: a case report
por: Chen, Can, et al.
Publicado: (2020)

Radiotherapy Plus Concurrent or Sequential Temozolomide for Glioblastoma in the Elderly: A Meta-Analysis
por: Yin, An-an, et al.
Publicado: (2013)

Hoxd10 Is Required Systemically for Secretory Activation in Lactation and Interacts Genetically with Hoxd9
por: Landua, John D., et al.
Publicado: (2020)

Exploring the Mechanism of Adjuvant Treatment of Glioblastoma Using Temozolomide and Metformin
por: Feng, Shao-Wei, et al.
Publicado: (2022)

STAT3-mediated upregulation of LINC00520 contributed to temozolomide chemoresistance in glioblastoma by interacting with RNA-binding protein LIN28B
por: Yuan, Shuai, et al.
Publicado: (2022)

BET protein inhibition sensitizes glioblastoma cells to temozolomide treatment by attenuating MGMT expression
por: Tancredi, Alessandro, et al.
Publicado: (2022)

Resveratrol Enhances Temozolomide Efficacy in Glioblastoma Cells through Downregulated MGMT and Negative Regulators-Related STAT3 Inactivation
por: Wu, Moli, et al.
Publicado: (2023)

ALYREF Drives Cancer Cell Proliferation Through an ALYREF-MYC Positive Feedback Loop in Glioblastoma
por: Wang, Jianjun, et al.
Publicado: (2021)

HOXD9 promote epithelial‐mesenchymal transition and metastasis in colorectal carcinoma
por: Liu, Mengwei, et al.
Publicado: (2020)

Are There Thresholds in Glioblastoma Cell Death Responses Triggered by Temozolomide?
por: He, Yang, et al.
Publicado: (2019)

Combination therapy with micellarized cyclopamine and temozolomide attenuate glioblastoma growth through Gli1 down-regulation
por: Liu, Yu-Jie, et al.
Publicado: (2017)

Acquired temozolomide resistance in MGMT-deficient glioblastoma cells is associated with regulation of DNA repair by DHC2
por: Yi, Guo-zhong, et al.
Publicado: (2019)

Aberrant Expression of ADARB1 Facilitates Temozolomide Chemoresistance and Immune Infiltration in Glioblastoma
por: Lu, Can, et al.
Publicado: (2022)

Continuous dose-intense temozolomide and cisplatin in recurrent glioblastoma patients
por: Wang, Yu, et al.
Publicado: (2017)

Almonertinib Combined with Anlotinib and Temozolomide in a Patient with Recurrent Glioblastoma with EGFR L858R Mutation
por: Hou, Zhiwei, et al.
Publicado: (2023)

FBW7 is associated with prognosis, inhibits malignancies and enhances temozolomide sensitivity in glioblastoma cells
por: Lin, Jing, et al.
Publicado: (2018)

Making HoxD waves
por: Katsnelson, Alla
Publicado: (2006)

An evolving NGF–Hoxd1 signaling pathway mediates development of divergent neural circuits in vertebrates
por: Guo, Ting, et al.
Publicado: (2010)

Defactinib attenuates osteoarthritis by inhibiting positive feedback loop between H-type vessels and MSCs in subchondral bone
por: Hu, Yanjun, et al.
Publicado: (2020)

Evx2-Hoxd13 Intergenic Region Restricts Enhancer Association to Hoxd13 Promoter
por: Yamagishi, Takumi, et al.
Publicado: (2007)

Accelerated hyperfractionation plus temozolomide in glioblastoma
por: Kaul, David, et al.
Publicado: (2016)

Strategies of temozolomide in future glioblastoma treatment
por: Lee, Chooi Yeng
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_iaugcjnea70sibkaoif43squse